HLA AND PROGNOSIS IN MULTIPLE-SCLEROSIS

被引:59
作者
RUNMARKER, B [1 ]
MARTINSSON, T [1 ]
WAHLSTROM, J [1 ]
ANDERSEN, O [1 ]
机构
[1] OSTRA HOSP, DEPT CLIN GENET, S-41685 GOTHENBURG, SWEDEN
关键词
MULTIPLE SCLEROSIS; HLA ANTIGENS; PROGNOSIS; LIFE-TABLE ANALYSIS;
D O I
10.1007/BF02033356
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The patients of a multiple sclerosis (MS) incidence cohort with 25 years of longitudinal follow-up were typed for HLA-DR and DQ. This type of cohort provides reliable data for gene frequencies and prognostic studies. The influence of sampling bias, mainly due to mortality during the long follow-up, was accounted for. A positive association between MS and DR15,DQ6 was confirmed, but this haplotype did not influence prognosis. There was no difference in haplotype frequency between relapsing-remitting and primary chronic progressive MS. DR17,DQ2 was significantly over-represented in the quartile with the most malignant course. The haplotype DRI,DQ5, which was found rather less frequently in MS patients, also tended to be associated with a poorer prognosis.
引用
收藏
页码:385 / 390
页数:6
相关论文
共 38 条
[1]  
BATCHELOR JR, 1978, HISTOCOMPATIBILITY T, P207
[2]  
Bidwell J L, 1990, Baillieres Clin Haematol, V3, P355, DOI 10.1016/S0950-3536(05)80055-1
[3]   A DNA-RFLP TYPING SYSTEM THAT POSITIVELY IDENTIFIES SEROLOGICALLY WELL-DEFINED AND ILL-DEFINED HLA-DR AND DQ ALLELES, INCLUDING DRW10 [J].
BIDWELL, JL ;
BIDWELL, EA ;
SAVAGE, DA ;
MIDDLETON, D ;
KLOUDA, PT ;
BRADLEY, BA .
TRANSPLANTATION, 1988, 45 (03) :640-646
[4]   DNA-RFLP METHODS AND INTERPRETATION SCHEME FOR HLA-DR-TYPING AND DQ-TYPING [J].
BIDWELL, JL ;
BIGNON, JD .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1991, 18 (1-2) :5-22
[5]   HLA-DR-DQ HAPLOTYPES DEFINED BY RESTRICTION FRAGMENT ANALYSIS - CORRELATION TO SEROLOGY [J].
CARLSSON, B ;
WALLIN, J ;
BOHME, J ;
MOLLER, E .
HUMAN IMMUNOLOGY, 1987, 20 (02) :95-113
[6]   HLA ANTIGENS AND PROGRESSION OF MULTIPLE-SCLEROSIS .2. [J].
DEJAEGHER, L ;
DEBRUYERE, M ;
KETELAER, P ;
CARTON, H .
JOURNAL OF NEUROLOGY, 1983, 229 (03) :167-174
[7]   CLINICAL SUB-GROUPS OF MULTIPLE-SCLEROSIS IN RELATION TO HLA - DR ALLELES AS POSSIBLE MARKERS OF DISEASE PROGRESSION [J].
DUQUETTE, P ;
DECARY, F ;
PLEINES, J ;
BOIVIN, D ;
LAMOUREUX, G ;
COSGROVE, JBR ;
LAPIERRE, Y .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1985, 12 (02) :106-110
[8]   A POPULATION-BASED STUDY OF MULTIPLE-SCLEROSIS IN TWINS [J].
EBERS, GC ;
BULMAN, DE ;
SADOVNICK, AD ;
PATY, DW ;
WARREN, S ;
HADER, W ;
MURRAY, TJ ;
SELAND, TP ;
DUQUETTE, P ;
GREY, T ;
NELSON, R ;
NICOLLE, M ;
BRUNET, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (26) :1638-1642
[9]   HLA AND HETEROGENEITY OF MULTIPLE-SCLEROSIS [J].
ENGELL, T ;
RAUN, NE ;
THOMSEN, M ;
PLATZ, P .
NEUROLOGY, 1982, 32 (09) :1043-1046
[10]   MULTIPLE-SCLEROSIS IN NORTHEAST SCOTLAND - AN ASSOCIATION WITH HLA-DQW1 [J].
FRANCIS, DA ;
BATCHELOR, JR ;
MCDONALD, WI ;
HING, SN ;
DODI, IA ;
FIELDER, AHL ;
HERN, JEC ;
DOWNIE, AW .
BRAIN, 1987, 110 :181-196